NCT00733174View on ClinicalTrials.gov

Rosiglitazone Therapy In The Prevention Of Coronary Artery Disease In Patients With Impaired Glucose Tolerance

PHASE4UnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

January 31, 2009

Conditions
Impaired Glucose Tolerance
Interventions
DRUG

Rosiglitazone

tablet

DRUG

Placebo

Trial Locations (1)

80219

RECRUITING

South Federal Family Practice, Denver

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Denver Research Institute

OTHER